HOME >> MEDICINE >> NEWS
ACP guidelines: Many diabetics should be taking statins

All people with type 2 diabetes mellitus and coronary artery disease (CAD), and all people with diabetes and any other risk for cardiovascular disease, should be taking cholesterol-lowering drugs called statins, the American College of Physicians (ACP) said in new guidelines published in the April 20, 2004, issue of Annals of Internal Medicine.

This is the second ACP guideline on aggressive management of risk factors for cardiovascular disease in people with type 2 diabetes. In April 2003, ACP called for tight control of blood pressure for people with diabetes.

An estimated 80 percent of people with type 2 diabetes will develop or die of complications of heart and vessel disease, and about 65 percent of deaths among people with diabetes are due to heart disease and stroke, according to the American Diabetes Association.

"We want both physicians and patients to know that when treating diabetes, controlling cardiovascular risk factors, particularly cholesterol levels and high blood pressure, is as important as controlling blood sugar," said Vincenza Snow, MD, FACP, senior medical associate in the department of scientific policy at the American College of Physicians.

"This is life-saving information," Dr. Snow said "In addition to controlling blood sugar levels, people with diabetes may be surprised to know that they must also be vigilant about controlling their blood pressure and cholesterol levels."

The numbers of people with type 2 diabetes is growing rapidly in the United States. An estimated 18.2 million Americans, or about six percent of the population, have type 2 diabetes, and an additional 1.3 million people aged 20 or older are diagnosed with the disease each year, according to the American Diabetes Association. Some call this increase an epidemic.

The new ACP guidelines are targeted at both patients and primary care physicians. For patients, ACP is issuing a video news release to alert
'"/>

Contact: Susan Anderson
sanderson@acponline.org
215-351-2653
American College of Physicians
19-Apr-2004


Page: 1 2 3

Related medicine news :

1. Update on cholesterol guidelines: more-intensive treatment options for higher risk patients
2. Study of obese diabetics explains why low-carb diets produce fast results
3. University health study identifies undiagnosed diabetics
4. Heart attack, stroke risk overlooked in diabetics
5. Isolated soy protein shown to benefit type 2 diabetics, study indicates
6. New initiative to focus on growing problem of cardiovascular disease in diabetics
7. One in 12 diabetics over age 40 has vision-threatening eye disease
8. Optical glucose sensor holds promise for diabetics and intensive care patients
9. Life expectancy of diabetics 12 years less than others
10. Emory data suggest diabetics have worsening symptoms prior to acute cardiac event
11. Anti-coagulation drugs found to have different effects in diabetics after heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... ... years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could ... after surgery, though activity levels decline over time. The study, presented today at ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... why concussion rates are on the rise, say researchers presenting their work at ... Toronto, Ontario, Canada. , “The combination of evaluating the patterns of change in ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
(Date:7/20/2017)... NY, July 20, 2017 (PRWEB) , ... ... ... Nastel Technologies, a global provider of enterprise-grade IT operations analytics and application ... arm of one of world’s largest healthcare services providers. , According to ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... a clinical-stage pharmaceutical company focused on the development of oral ... from the Israel Securities Authority to dual-list its common stock ... will commence trading on the TASE on July 12, 2017 ... of the Company, it is expected that Oramed will be ...
(Date:7/5/2017)... Wash. , July 5, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... cryopreservation freeze media ("BioLife"), today announced that it ... its debt holder and largest shareholder, to modify its ... Pursuant to the modification, WAVI agreed to exchange ...
(Date:6/30/2017)... In vitro diagnostics market firm Kalorama Information ... least ten diagnostic companies have successfully completed financings.  The ... a loan facility.  The size of these financings ranged ... Information provides a monthly IVD Market Trends Report ... "Diagnostics deals ...
Breaking Medicine Technology:
Cached News: